Differing requirements for CCR4, E-selectin, and α4β1 for the migration of memory CD4 and activated T cells to dermal inflammation.
CCR4 on T cells is suggested to mediate skin homing in mice. Our objective was to determine the interaction of CCR4, E-selectin ligand (ESL), and α(4)β(1) on memory and activated T cells in recruitment to dermal inflammation. mAbs to rat CCR4 were developed. CCR4 was on 5-21% of memory CD4 cells, and 20% were also ESL(+). Anti-TCR-activated CD4 and CD8 cells were 40-55% CCR4(+), and ∼75% of both CCR4(+) and CCR4(-) cells were ESL(+). CCR4(+) memory CD4 cells migrated 4- to 7-fold more to dermal inflammation induced by IFN-γ, TNF, TLR agonists, and delayed-type hypersensitivity than CCR4(-) cells. CCR4(+) activated CD4 cells migrated only 5-50% more than CCR4(-) cells to these sites. E-selectin blockade inhibited ∼60% of CCR4(+) activated CD4 cell migration but was less effective on memory cells where α(4)β(1) was more important. Anti-α(4)β(1) also inhibited CCR4(-) activated CD4 cells more than CCR4(+) cells. Anti-E-selectin reduced activated CD8 more than CD4 cell migration. These findings modify our understanding of CCR4, ESL, α(4)β(1), and dermal tropism. There is no strict relationship between CCR4 and ESL for skin homing of CD4 cells, because the activation state and inflammatory stimulus are critical determinants. Dermal homing memory CD4 cells express CCR4 and depend more on α(4)β(1) than ESL. Activated CD4 cells do not require CCR4, but CCR4(+) cells are more dependent on ESL than on α(4)β(1), and CCR4(-) cells preferentially use α(4)β(1). The differentiation from activated to memory CD4 cells increases the dependence on CCR4 for skin homing and decreases the requirement for ESL.
Department of Pediatrics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3K 6R8, Canada.
Ahmed
A
Gehad
Nadia A
NA
Al-Banna
Maria
M
Vaci
Andrew C
AC
Issekutz
Karkada
K
Mohan
Markus
M
Latta
Thomas B
TB
Issekutz
D000818:Animals; D016466:CHO Cells; D002464:Cell Migration Inhibition / Q000276:immunology; D002465:Cell Movement / Q000276:immunology*; D006224:Cricetinae; D003412:Cricetulus; D004195:Disease Models, Animal; D019040:E-Selectin / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D007156:Immunologic Memory; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D039041:Integrin alpha4beta1 / Q000037:antagonists & inhibitors / Q000502:physiology*; D008213:Lymphocyte Activation / Q000276:immunology*; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000502:physiology; D051381:Rats; D011917:Rats, Inbred Lew; D054398:Receptors, CCR4 / Q000096:biosynthesis / Q000172:deficiency / Q000502:physiology*; D017468:Receptors, Fibroblast Growth Factor / Q000096:biosynthesis; D012795:Sialoglycoproteins / Q000096:biosynthesis; D012867:Skin / Q000276:immunology* / Q000473:pathology; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism / Q000473:pathology
C515356:Ccr4 protein, rat; D019040:E-Selectin; D039041:Integrin alpha4beta1; D008562:Membrane Glycoproteins; C084882:P-selectin ligand protein; D054398:Receptors, CCR4; D017468:Receptors, Fibroblast Growth Factor; D012795:Sialoglycoproteins; C086711:cysteine-rich fibroblast growth factor receptor